Endocannabinoid system: An overview of its potential in current medical practice.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing preclinical mechanisms and clinical potential without systematic review methodology
What was done
This paper is a narrative review summarizing the biological components, physiological functions, and therapeutic potential of the endocannabinoid system (ECS). It examines the distribution and roles of cannabinoid receptors (CB1 and CB2), endogenous ligands (anandamide and 2-AG), synthesis/degradation pathways (FAAH and MAGL), and discusses clinical developments, including CB1 antagonism in metabolic syndrome and roles in mammalian reproduction.
What was found
The abstract presents a descriptive overview with no quantitative data or effect sizes reported. It describes the ECS as a retrograde lipid signaling system acting at GABAergic and glutamatergic synapses and peripheral organs (adipose tissue, liver, pancreas, gut, immune system, reproductive organs). The review notes that rimonabant, a CB1 blocker evaluated in phase III trials for cardiometabolic risk and obesity, regulated intra-abdominal fat, glycemic, lipidemic, and inflammatory markers, but was withdrawn due to safety concerns. Preclinical evidence also implicates endocannabinoid signaling in fertilization, spermatogenesis, and embryo preimplantation.
Why it matters
The review synthesizes the broad scope of ECS signaling across central and peripheral tissues, highlighting its promise for treating metabolic, behavioral, and reproductive disorders while emphasizing the clinical safety hurdles associated with systemic receptor blockade.
Limits
The paper is a non-systematic narrative review providing no primary clinical trial data, quantitative meta-analyses, or study selection criteria. Details regarding the specific phase III trial results or specific mechanisms of adverse events leading to rimonabant's withdrawal are not quantified in the abstract.
Cited by
- supports The human endocannabinoid receptor system is distributed throughout both the brain and the peripheral body.